---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-143057"
form_type: "8-K/A"
ticker: "TWST"
cik: "0001581280"
company_name: "Twist Bioscience Corp"
filed_at: "2021-11-23T23:59:59+00:00"
generated_at: "2026-06-28T05:46:23.388775+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Twist Bioscience appoints Dr. Melissa Starovasnik to Compensation Committee

## Summary
- Dr. Melissa Starovasnik was appointed to the Compensation Committee of the Board on November 17, 2021.
- She was originally elected as a Class I director effective August 5, 2021, as previously reported.
- The amendment solely adds this committee assignment; no other changes to prior disclosure.

## SEC filing metadata
- accession: 0001104659-21-143057
- form_type: 8-K/A
- ticker: TWST
- cik: 0001581280
- company_name: Twist Bioscience Corp
- filed_at: 2021-11-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1581280/000110465921143057/0001104659-21-143057-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1581280/000110465921143057/tm2133571d2_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-143057
- JSON: https://secwatch.observer/filing/0001104659-21-143057.json
- Plain text: https://secwatch.observer/filing/0001104659-21-143057.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.